These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
564 related items for PubMed ID: 16427029
1. A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Rujescu D, Bender A, Keck M, Hartmann AM, Ohl F, Raeder H, Giegling I, Genius J, McCarley RW, Möller HJ, Grunze H. Biol Psychiatry; 2006 Apr 15; 59(8):721-9. PubMed ID: 16427029 [Abstract] [Full Text] [Related]
2. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist. Perera PY, Lichy JH, Mastropaolo J, Rosse RB, Deutsch SI. Eur Neuropsychopharmacol; 2008 Nov 15; 18(11):814-9. PubMed ID: 18674888 [Abstract] [Full Text] [Related]
3. MK-801 prevents the increased NMDA-NR1 and NR2B subunits mRNA expression observed in the hippocampus of rats tolerant to diazepam. Almirón RS, Pérez MF, Ramírez OA. Brain Res; 2004 May 15; 1008(1):54-60. PubMed ID: 15081382 [Abstract] [Full Text] [Related]
4. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus. Pandis C, Sotiriou E, Kouvaras E, Asprodini E, Papatheodoropoulos C, Angelatou F. Neuroscience; 2006 Jun 19; 140(1):163-75. PubMed ID: 16542781 [Abstract] [Full Text] [Related]
5. Lack of functional expression of NMDA receptors in PC12 cells. Edwards MA, Loxley RA, Williams AJ, Connor M, Phillips JK. Neurotoxicology; 2007 Jul 19; 28(4):876-85. PubMed ID: 17572500 [Abstract] [Full Text] [Related]
6. Kinetics and subunit composition of NMDA receptors in respiratory-related neurons. Paarmann I, Frermann D, Keller BU, Villmann C, Breitinger HG, Hollmann M. J Neurochem; 2005 May 19; 93(4):812-24. PubMed ID: 15857385 [Abstract] [Full Text] [Related]
7. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat. Klamer D, Zhang J, Engel JA, Svensson L. Behav Brain Res; 2005 Apr 15; 159(1):95-103. PubMed ID: 15795002 [Abstract] [Full Text] [Related]
8. N-methyl-D-aspartate receptor-dependent long-term potentiation in CA1 region affects synaptic expression of glutamate receptor subunits and associated proteins in the whole hippocampus. Zhong WX, Dong ZF, Tian M, Cao J, Xu L, Luo JH. Neuroscience; 2006 Sep 01; 141(3):1399-413. PubMed ID: 16766131 [Abstract] [Full Text] [Related]
9. Chronic stress attenuates GABAergic inhibition and alters gene expression of parvocellular neurons in rat hypothalamus. Verkuyl JM, Hemby SE, Joëls M. Eur J Neurosci; 2004 Sep 01; 20(6):1665-73. PubMed ID: 15355334 [Abstract] [Full Text] [Related]
10. Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophrenia. Mastropaolo J, Rosse RB, Deutsch SI. Behav Brain Res; 2004 Aug 31; 153(2):419-22. PubMed ID: 15265637 [Abstract] [Full Text] [Related]
12. Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats--a possible model for schizophrenia. Baier PC, Blume A, Koch J, Marx A, Fritzer G, Aldenhoff JB, Schiffelholz T. Behav Brain Res; 2009 Dec 14; 205(1):96-101. PubMed ID: 19539658 [Abstract] [Full Text] [Related]
14. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801. Seillier A, Giuffrida A. Behav Brain Res; 2009 Dec 07; 204(2):410-5. PubMed ID: 19716985 [Abstract] [Full Text] [Related]
15. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist. Losi G, Lanza M, Makovec F, Artusi R, Caselli G, Puia G. Neuropharmacology; 2006 Mar 07; 50(3):277-85. PubMed ID: 16236334 [Abstract] [Full Text] [Related]
16. Differential responses to NMDA receptor activation in rat hippocampal interneurons and pyramidal cells may underlie enhanced pyramidal cell vulnerability. Avignone E, Frenguelli BG, Irving AJ. Eur J Neurosci; 2005 Dec 07; 22(12):3077-90. PubMed ID: 16367774 [Abstract] [Full Text] [Related]
17. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof]. Xiao ZY, Sun CK, Xiao XW, Lin YZ, Li S, Ma H, Song GR, Cheng R. Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2479-84. PubMed ID: 17156678 [Abstract] [Full Text] [Related]
18. Modulatory effects of d-serine and sarcosine on NMDA receptor-mediated neurotransmission are apparent after stress in the genetically inbred BALB/c mouse strain. Long KD, Mastropaolo J, Rosse RB, Manaye KF, Deutsch SI. Brain Res Bull; 2006 May 31; 69(6):626-30. PubMed ID: 16716829 [Abstract] [Full Text] [Related]
19. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1). Manahan-Vaughan D, Wildförster V, Thomsen C. Eur J Neurosci; 2008 Oct 31; 28(7):1342-50. PubMed ID: 18973561 [Abstract] [Full Text] [Related]
20. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine. Nabeshima T, Mouri A, Murai R, Noda Y. Ann N Y Acad Sci; 2006 Nov 31; 1086():160-8. PubMed ID: 17185514 [Abstract] [Full Text] [Related] Page: [Next] [New Search]